A pharmacy technician identifies a medication error involving a confusing drug name and informs the pharmacist. Which FDA program can receive a report of the error?
AMedWatch✓ Correct
FDA identifies MedWatch as a route for reporting medication errors.
BREMS@FDA✗ Incorrect
REMS materials describe medication-specific safety programs, rather than serving as the cited error-reporting route.
CA recall classification✗ Incorrect
A recall class describes a product hazard, not the reporting program.
DTall-man lettering✗ Incorrect
Lettering distinguishes names; it is not a reporting program.
Answer
A. MedWatch
Rationale
FDA encourages reports when drug names contribute to errors. MedWatch is a route for reporting those events to FDA.
RememberReport medication errors to FDA through MedWatch.
Sources
Drug Name ReviewU.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · Video Transcript · page updated Thu, 03/03
What's in a REMS?U.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · Current REMS · page updated Fri, 01/26
FDA Name Differentiation ProjectU.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · FDA List of Established Drug Names Recommended to Use Tall Man Lettering (TML) · page updated Fri, 06/12
Medication Errors:U.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · Page 43
Last verified: 2 independent automated checksQuestion ptcb-psqa-00016, version 1
Checks are automated. No licensed clinician has reviewed this question. Check the sources and your program’s materials.
